B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

The Jonathan Jaques Children's Cancer Institute at Miller Children's & Women's Hospital was involved in a pivotal Children's Oncology Group study that has reshaped the standard of care for children ...

Despite failing to achieve MRD-negativity after induction, patients with Ph+ acute lymphoblastic leukemia treated with ...

Fifty-two cancer survivors and their families came together in the East Valley to celebrate the strength and resilience of pediatric cancer patients.

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results ...

When Miranda Aldridge first noticed a tiny bump near her daughter Cameron’s eye, it didn’t seem alarming, just unusual. But ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...